Lung cancer (internet-based) Delphi (LUCiD): A modified eDelphi consensus process to establish Australasian clinical quality indicators for thoracic cancer.

Autor: Nash J; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia., Stone E; Department of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.; School of Clinical Medicine, St Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Vinod S; South West Sydney Clinical Campuses, University of New South Wales, Sydney, New South Wales, Australia.; Cancer Therapy Centre, Liverpool Hospital, Sydney, New South Wales, Australia., Leong T; Department of Respiratory and Sleep Medicine, Austin Health, Melbourne, Victoria, Australia., Dawkins P; Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand.; Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Stirling RG; Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Monash University, Melbourne, Victoria, Australia., Harden S; Central Clinical School, Monash University, Melbourne, Victoria, Australia.; University of Melbourne, Melbourne, Victoria, Australia.; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Bolton A, McWilliams A; Department of Respiratory Medicine, Fiona Stanley Hospital, Perth, Western Australia, Australia.; University of Western Australia, Perth, Western Australia, Australia., O'Byrne K; Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.; Queensland University of Technology, Brisbane, Queensland, Australia., Wright GM; University of Melbourne, Melbourne, Victoria, Australia.; Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.; Department of Cardiothoracic Surgery, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia., Brunelli VN; Faculty of Science, Medicine, and Health, University of Wollongong, Wollongong, New South Wales, Australia., Guan T; Cancer Alliance Queensland, Brisbane, Queensland, Australia., Philpot S; Cancer Alliance Queensland, Brisbane, Queensland, Australia., Navani N; Department of Thoracic Medicine, University College London Hospital, London, UK.; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK., Brims F; Curtin Medical School, Curtin University, Perth, Western Australia, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; National Centre for Asbestos Related Diseases, Institute for Respiratory Health, Perth, Western Australia, Australia.
Jazyk: angličtina
Zdroj: Respirology (Carlton, Vic.) [Respirology] 2024 Dec; Vol. 29 (12), pp. 1085-1094. Date of Electronic Publication: 2024 Aug 13.
DOI: 10.1111/resp.14812
Abstrakt: Background and Objective: Approximately 16,000 new cases of lung cancer are diagnosed each year in Australia and Aotearoa New Zealand, and it is the leading cause of cancer death in the region. Unwarranted variation in lung cancer care and outcomes has been described for many years, although clinical quality indicators to facilitate benchmarking across Australasia have not been established. The purpose of this study was to establish clinical quality indicators applicable to lung and other thoracic cancers across Australia and Aotearoa New Zealand.
Methods: Following a literature review, a modified three round eDelphi consensus process was completed between October 2022 and June 2023. Participants included clinicians from all relevant disciplines, patient advocates, researchers and other stakeholders, with representatives from all Australian states and territories and Aotearoa New Zealand. Consensus was set at a threshold of 70%, with the first two rounds conducted as online surveys, and the final round held as a hybrid in person and virtual consensus meeting.
Results: The literature review identified 422 international thoracic oncology indicators, and a total of 71 indicators were evaluated over the course of the Delphi consensus. Ultimately, 27 clinical quality indicators reached consensus, covering the continuum of thoracic oncologic care from diagnosis to first line treatment. Indicators benchmarking supportive care were poorly represented. Attendant numeric quality standards were developed to facilitate benchmarking.
Conclusion: Twenty-seven clinical quality indicators relevant to thoracic oncology care in Australasia were developed. Real world implementation will now be explored utilizing a prospective dataset collected across Australia.
(© 2024 The Author(s). Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.)
Databáze: MEDLINE
Externí odkaz: